CLINICAL_TRIALS
trial_result
· 2022-08-26
Clinical Trial Update: NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery [EARLY_Phase 1]
Summary
A Phase 1 trial of NU-0129 in patients with recurrent glioblastoma or gliosarcoma undergoing surgery has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Gliosarcoma, Recurrent Glioblastoma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-08-26